London Daily

Focus on the big picture.
Tuesday, Jul 22, 2025

Russia says its Sputnik V vaccine against Covid-19 is 95% effective

Russia says its Sputnik V vaccine against Covid-19 is 95% effective

Russia said Tuesday that its Sputnik V vaccine against Covid-19, developed by the Gamaleya research center in Moscow, is 95% effective.
These are preliminary results obtained with volunteers 42 days after the injection of the first dose, indicated in a joint statement from the center, the Russian Ministry of Health and the Russian Sovereign Fund involved in the development of the vaccine.

The price of a dose of Sputnik V in the international market will be less than 10 dollars, the Russian Sovereign Fund announced in a separate statement, while for Russian citizens the vaccine will be free.

The Sputnik V vaccine is currently in phase 3 of double-blind, randomized clinical trials with about 40,000 volunteers.

The vaccine creators reiterated Tuesday that the research data will be published shortly in one of the world's leading peer-reviewed medical journals.

It is a vaccine based on the "viral vector", which uses two injections of two adenoviruses (a very common type of virus that causes colds) modified with a part of the virus responsible for Covid-19.

When the modified adenovirus enters the cells of vaccinated people, they make a typical SARS-CoV-2 protein, allowing the immune system to recognize the virus and fight it, as explained by the Gamaleya center.

Competition is fierce to develop a vaccine to curb the coronavirus pandemic that has plagued the world since the beginning of the year.

The British laboratory AstraZeneca and the University of Oxford published Monday that their vaccine had an average effectiveness of 70%.

For its part, the vaccine developed between Pfizer and BioNTech is 95% effective, according to the complete results of its large-scale clinical trial, which were released last week. The American company Moderna announced similar results (94.5% effective).

Russia is ready to fight to lead the vaccine race and, already in August it announced that Sputnik V was very effective.

The topic of vaccination divides opinions. Some believe that it is the path back the normality before covid-19, others are highly skeptical that the vaccines have been developed in such rush, and doubt that the testing and trials would be sufficient to provide their safety to humans.
Newsletter

Related Articles

0:00
0:00
Close
US Treasury Secretary Calls for Institutional Review of Federal Reserve Amid AI‑Driven Growth Expectations
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Severe Flooding in South Korea Claims Lives Amid Ongoing Rescue Operations
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
CEO Resigns Amid Controversy Over Relationship with HR Executive
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
Epstein Files Deepen Republican Party Divide
Zuckerberg Faces $8 Billion Privacy Lawsuit From Meta Shareholders
FIFA Pressured to Rethink World Cup Calendar Due to Climate Change
SpaceX Nears $400 Billion Valuation With New Share Sale
Microsoft, US Lab to Use AI for Faster Nuclear Plant Licensing
Trump Walks Back Talk of Firing Fed Chair Jerome Powell
Zelensky Reshuffles Cabinet to Win Support at Home and in Washington
"Can You Hit Moscow?" Trump Asked Zelensky To Make Putin "Feel The Pain"
Irish Tech Worker Detained 100 days by US Authorities for Overstaying Visa
Dimon Warns on Fed Independence as Trump Administration Eyes Powell’s Succession
Church of England Removes 1991 Sexuality Guidelines from Clergy Selection
Superman Franchise Achieves Success with Latest Release
Hungary's Viktor Orban Rejects Agreements on Illegal Migration
Jeff Bezos Considers Purchasing Condé Nast as a Wedding Gift
Ghislaine Maxwell Says She’s Ready to Testify Before Congress on Epstein’s Criminal Empire
Bal des Pompiers: A Celebration of Community and Firefighter Culture in France
FBI Chief Kash Patel Denies Resignation Speculations Amid Epstein List Controversy
Air India Pilot’s Mental Health Records Under Scrutiny
Google Secures Windsurf AI Coding Team in $2.4 Billion Licence Deal
Jamie Dimon Warns Europe Is Losing Global Competitiveness and Flags Market Complacency
South African Police Minister Suspended Amid Organised Crime Allegations
Nvidia CEO Claims Chinese Military Reluctance to Use US AI Technology
Hong Kong Advances Digital Asset Strategy to Address Economic Challenges
Australia Rules Out Pre‑commitment of Troops, Reinforces Defence Posture Amid US‑China Tensions
Martha Wells Says Humanity Still Far from True Artificial Intelligence
Nvidia Becomes World’s First Four‑Trillion‑Dollar Company Amid AI Boom
U.S. Resumes Deportations to Third Countries After Supreme Court Ruling
Excavation Begins at Site of Mass Grave for Children at Former Irish Institution
×